Anticoagulant pharmaceutical monitoring management method based on clinical data

Abstract

The invention discloses an anticoagulant pharmaceutical monitoring management method based on clinical data. The method is characterized by comprising the following steps: step 1, realizing clinical data acquisition and processing; step 2, realizing group entry evaluation of monitored patients; and step 3, realizing active monitoring and real-time early warning. Patients needing to be subjected toanticoagulation pharmaceutical monitoring can be automatically brought into pharmaceutical monitoring, and automatic, intelligent and active monitoring and real-time early warning are conducted on the monitored patients according to a monitoring early warning model. Therefore, the anticoagulation treatment effect is greatly improved, serious adverse events such as bleeding and stroke are reduced;meanwhile, the anticoagulation pharmacy monitoring work efficiency of clinical pharmacists is greatly improved.

Description

technical field [0001] The invention relates to the related fields of data monitoring and management, in particular to an anticoagulant pharmaceutical monitoring and management method based on clinical data. Background technique [0002] Anticoagulant therapy is the most important means of clinical prevention and treatment of thromboembolism, atrial fibrillation, venous thromboembolism (VTE), heart valve disease, artificial valve replacement, and the prevention of new and recurrent ischemic stroke. effective method. A number of large-scale clinical studies have confirmed that anticoagulant therapy and monitoring intervention can significantly reduce the incidence of ischemic stroke in patients with atrial fibrillation and effectively improve the prognosis. Statistics show that the incidence of stroke in patients with atrial fibrillation in my country is as high as 24.8%. Atrial fibrillation increases the risk of ischemic stroke and systemic arterial embolism, with annual i...

AI Technical Summary

Problems solved by technology

Clinical pharmacists use manual methods to judge which patients need to receive anticoagulant pharmaceutical care after reviewing various clinical diagnosis and treatment information of patients and combining with the consensus of anticoagulant-related clinical guidelines; In changing conditions, clinical pharmacists cannot keep track of each patient's treatment process, curative effect and whether adverse reactions occur; clinical pharmacists' monitoring level is also limited by personal professional level, so it is difficult for clinical pharmacists to monitor each patient receiving anticoagulant pharmaceutical care All of them can provide 100% accurate and efficient pharmaceutical care, which makes it difficult to conduct active monitoring and real-time early warning of serious adverse reactions such as intracranial hemorrhage and venous embolism that may occur clinically.

Images